Supernus Pharmaceuticals Inc.
Supernus develops and sells FDA‑approved CNS therapeutics such as Qelbree (ADHD) and GOCOVRI (PD), plus high‑potential pipeline candidates in epilepsy, depression, and Parkinson’s, positioning it for growth in neurological markets.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Hospitals and Health Care
- Industry: Medical Practices
- Employees: 674
- HQ: Rockville
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.